Cipla has a wide range of products and dosages forms, everything from nasal sprays, metered-dose inhalers, medical devices, trans-dermal spray patches, thermolabile foams, pre-filled syringes, and lyophilized injections.
Cipla has 7000 employees, who are known for their continuous quest for quality. For them quality is obsession.
Cipla had opened the door of hope to several AIDS patients by becoming the first company in the world to offer the Triple-drug AIDS Cocktail at a very low price. According to an estimate, one out of three HIV-AIDS patients in Africa takes Cipla drug for the treatment.
In partnership with the medical fraternity, Cipla has spread awareness and empowered asthma patients to lead a normal life. It has the widest range of asthma medication and better delivery systems. Cipla is also dedicated to clinical and allied research in the field of Chronic Respiratory Diseases.
Recently, the company has entered into agreement with a global non-profit organization for developing and manufacturing Drugs for Neglected diseases Initiative (DNDi) for a new anti-malarial combination drug.
Corporate Address:
Cipla Ltd.
Mumbai Central
Mumbai 400 008
India.
Ph: 022-23082891
022-23095521
Fax: 91-22-2307-0013
91-22-2307-0393
Quarterly Reports of Cipla
Quarterly Results (Rs. in Millions) |
|
Dec 2006 (3 rd quarter) |
Sept 2006
(2nd quarter) |
Dec 2005 (3 rd quarter) |
|
Sales Turnover |
9045 |
9152.6 |
8119.2 |
Other Income |
261.3 |
189.9 |
744.5 |
Total Income |
9306.3 |
9342.5 |
8863.7 |
Total Expenditure |
6852.3 |
6876.6 |
6529.9 |
Operating Profit |
2454 |
2465.9 |
2333.8 |
Interest |
13.2 |
15.6 |
50.7 |
Gross Profit |
2440.8 |
2450.3 |
2283.1 |
Depreciation |
275 |
245 |
230 |
Tax |
322 |
402.5 |
300 |
Reported PAT |
1843.8 |
1802.8 |
1753.1 |
*Source: economictimes.indiatimes.com
Quarterly Results (in %) |
|
% Change (Over Sep 2006)
|
% Change (Over Dec 2005)
|
|
|
Sales Turnover |
-1.18 |
11.4 |
Other Income |
37.6 |
-64.9 |
Total Income |
-0.39 |
4.99 |
Total Expenditure |
-0.35 |
4.94 |
Operating Profit |
-0.48 |
5.15 |
Interest |
-15.38 |
-73.96 |
Gross Profit |
-0.39 |
6.91 |
Depreciation |
12.24 |
19.57 |
Tax |
|
|
Reported PAT |
2.27 |
5.17 |
*Source: economictimes.indiatimes.com
Annual Results of Cipla
Annual Unaudited Results (Rs. in Millions) |
|
(12 Months) |
(12 Months) |
% Changes |
Sales Turnover |
31,142.00 |
24,008.70 |
29.71 |
Other Income |
1,216.30 |
819.8 |
48.37 |
Total Income |
32,358.30 |
24,828.50 |
30.33 |
Total Expenditure |
24,343.90 |
19,055.60 |
27.75 |
Operating Profit |
8,014.40 |
5,772.90 |
38.83 |
Interest |
114.2 |
76.3 |
49.67 |
Gross Profit |
7,900.20 |
5,696.60 |
38.68 |
Depreciation |
801.8 |
550.5 |
45.65 |
Tax |
1,022.00 |
1,050.00 |
-2.67 |
Reported PAT |
6,076.40 |
4,096.10 |
48.35 |
*Source: economictimes.indiatimes.com
|
